摘要
目的探讨厄贝沙坦联合氢氯噻嗪治疗老年性高血压病的临床疗效。方法 300例老年性高血压患者,分成对照组和观察组。对照组给予厄贝沙坦治疗;观察组给予厄贝沙坦联合氢氯噻嗪治疗。结果观察组总有效率(87.33%)高于对照组(72.67%),差异有统计学意义(P<0.01)。观察组收缩压、舒张压分别为(125.7±8.2)mm Hg、(74.1±5.7)mm Hg低于对照组收缩压、舒张压(136.3±9.2)mm Hg、(85.7±10.1)mm Hg,差异均有统计学意义(P<0.01)。结论厄贝沙坦联合氢氯噻嗪治疗老年性高血压病疗效佳,能有效改善患者血压水平。
Objective To study the clinical efficacy of irbesartan combined with hydrochlorothiazide in the treatment of senile hypertension. Methods 300 cases of elderly hypertensive patients were divided into the observation group and the control group. The control group was given irbesartan treatment. The observation group was given irbesartan combined with hydrochlorothiazide treatment. Results The observation group the total effective rate was 87.33% higher than 72.67% in the control group, the difference was statistically significant （P 〈 0.01）. The observation group systolic blood pressure, diastolic blood pressure were （125.7 ±8.2） mm Hg, （74.1 ±5.7） mm Hg lower than that of the control group, the systolic blood pressure, diastolic blood pressure （136.3 ±9.2） mm Hg, （85.7 ±10.1） mm Hg, the difference was statistically significant （P 〈 0.01）. Conclusion Combination of irbesartan and hydrochlorothiazide in treatment of senile hypertension is good, can effectively improve the blood pressure level of patients.
出处
《中国医药科学》
2013年第17期114-115,共2页
China Medicine And Pharmacy
关键词
厄贝沙坦
氢氯噻嗪
老年性高血压病
Irbesartan
Hydrochlorothiazide
Essential hypertension disease
